Home / Auditor changes / ZyVersa Therapeutics, Inc.
Filed 2025-04-07 路 Form 8-K 路 Accession 0001641172-25-003034 nano
Price before filing: $0.6174 (2025-04-04 close, split/dividend-adjusted)
Market cap at flag: $28.0M (2025-04-07) 路 Latest: $388.6M (2026-10-15)
| Window | ZVSA | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +10.9% | +11.1% | -0.1% | 2025-05-07 |
| 90 days | +6.9% | +23.2% | -16.3% | 2025-07-07 |
| 180 days | -74.1% | +33.7% | -107.8% | 2025-10-06 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"On April 4, 2025, Marcum resigned as the Company's independent registered public accounting firm, and with the approval of the Audit Committee of the Company's Board of Directors, the Company engaged CBIZ CPAs as the Company's independent registered public accounting firm, effective as of April 7, 2025."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: routine (audit-firm merger)
Disagreements reported: no
Former auditor: Marcum LLP · New auditor: CBIZ CPAs P.C.
Why this score: routine: audit firm merged/was acquired; also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.